Skip to main content
Fig. 6 | Journal of Biomedical Science

Fig. 6

From: Interleukin-20 is involved in dry eye disease and is a potential therapeutic target

Fig. 6

7E treatment produced protective effects against LGE-induced aqueous tear-deficient DED. A mouse model of aqueous tear-deficient DED induced by surgical removal of the extra-orbital lacrimal glands on the first day of the experiment. Sham surgery was used as control mice. Mice were treated with drugs, including PBS, Xiidra, mIgG, 7E (each group, n = 5) twice a day starting on day 8, and all mice were sacrificed on day 14. a Corneal epithelial integrity was analyzed by corneal fluorescein staining on days 4, 7, 10, and 14. Representative images were taken by Micron IV with a cobalt blue filter. b Fluorescein scores were blindly assessed by four individuals. One-way ANOVA, *p < 0.05, ***p < 0.001, and ****p < 0.0001. Data are shown as the mean ± SEM. c Tear production was measured at the same time on days 4, 7, 10, and 14. One-way ANOVA, **p < 0.01 and ***p < 0.001. Data are shown as the mean ± SEM. d Corneal mRNA transcripts of Il1b, Il6, F4/80, Nos2, Arg1, Mmp9, and Tnfa were analyzed by real-time PCR using specific primers. Conjunctival mRNA transcripts of Cd4, Il17a, and Ifnγ were also measured. Gapdh was used as an internal control. One-way ANOVA, *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001. Data are shown as the mean ± SEM. The experiments in a–d were repeated three times independently with similar results, and the data of one representative experiment was shown. LGE lacrimal gland excision, DED dry eye disease

Back to article page